Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Joint by Joint

Gretchen Henkel  |  Issue: November 2006  |  November 1, 2006

The Sharp score is very important for evaluating drug therapy, he notes. “Without a truly objective measure of what is happening to the joint structure, it would be very hard to understand to what extent a drug that makes patients feel better now is really doing something to their long-term health,” he says.

“This is the best we have right now—and as a matter of fact, I think it’s pretty good,” he says, adding, “I think scoring is a transient method. As soon as we have something that is really very efficient and very accurate, in terms of actual measurements, then people will say, ‘Why on earth did we ever bother with scoring?’ ”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

It is this kind of understated authority that makes Dr. Sharp such a well-respected figure in the field. To a person, each of his colleagues had universally positive things to say about Dr. Sharp. Dr. Strand expressed it most succinctly: “I don’t think I’ve ever met such an elegant man.”

References

  1. Sharp JT, Lidsky MD, Collins LC, Moreland J. Methods of scoring the progression of radiologic changes in rheumatoid arthritis: correlation of radiologic, clinical and laboratory abnormalities. Arthritis Rheum. 1971;14:706-720.
  2. Sigler JW, Bluhm GB, Duncan H, Sharp JT, Ensign DC. Gold salts in the treatment of rheumatoid arthritis: a double-blind study. Ann Intern Med. 1974;80:21-26.
  3. Van der Heijde DM, van Riel PL, et al. Effects of hydroxychloroquinine and sulphasalazine on progression of joint damage in rheumatoid arthritis. Lancet. 1989; 1:1036-1038.
  4. Strand V, Sharp JT. Radiographic data from recent randomized controlled trials in rheumatoid arthritis: What have we learned? Arthritis Rheum. 2003;48(1):21-34.

Career Timeline

  • 1947
    After serving as a student in uniform during World War II, Dr. Sharp graduates from the Columbia College of Physicians and Surgeons in New York City.
  • 1949
    Completes a two-year residency at Columbia Presbyterian Hospital, where he works with Charles Ragan, MD, chief of Presbyterian Hospital’s arthritis program.
  • 1951
    Completes a two-year residency at Dartmouth.
  • 1952
    On a tour of duty in the Navy during the Korean War, during which he is stationed in New Hampshire and Maryland.
  • 1953
    Begins rheumatology fellowship at Massachusetts General Hospital, working in their pioneering academic program under Walter Bauer, MD.
  • 1960
    Accepts a position at Henry Ford Hospital in Detroit, Mich.
  • 1962
    Becomes chief of rheumatology at Baylor College of Medicine in Houston, where he spends 15 years building a solid program.
  • 1976
    Accepts a position as chief of medicine at a VA hospital with the hope of building a new medical school at Champagne/Urbana. VA budget cuts prevent this, however.
  • 1980
    Moves to the Joe and Betty Alpert Arthritis Center in Denver.
  • 1986
    At age 62, faced with a retirement he was not quite ready for, Dr. Sharp joins a small medical clinic in Tifton, Ga.
  • 2006
    Now (mostly) retired, Dr. Sharp spends his days relaxing with his family and volunteering in his community when he is not working to develop new outcomes measures or collaborating with other rheumatology researchers.

Page: 1 2 3 4 5 6 | Single Page
Share: 

Filed under:Practice SupportProfilesResearch Rheum Tagged with:Clinical researchMetricsOutcome measuresRheumatoid Arthritis (RA)

Related Articles

    Remembrance of John Sharp, MD, Rheumatologist Extraordinaire

    December 1, 2008

    Dr. Sharp was a rheumatology pioneer who left a lasting mark on the field

    In the Lungs: Asthma & COPD May Be Early, Independent Risk Factors for RA

    June 1, 2020

    Recent research found women with COPD and asthma—even those who have never smoked—are at a higher risk of developing rheumatoid arthritis…

    The Great Debate: Should Jakinibs Be Used Before Biologics after Methotrexate Failure in RA?

    November 9, 2020

    ACR CONVERGENCE 2020—In many ways, the current plethora of treatment options for rheumatoid arthritis patients represents an embarrassment of riches. However, while many therapeutics approved by the U.S. Food & Drug Administration (FDA) are available, knowing the order in which to try these medications with patients can be quite challenging. In The Great Debate, held…

    Rheumatology’s Divergent Thinkers

    February 1, 2008

    OMERACT selects outcomes measures with an egalitarian process

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences